Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer Chunyan LiLin ZhangJunyao Li Review – Cancer Research 19 October 2019 Pages: 2875 - 2889
Correlations between microsatellite instability and the biological behaviour of tumours Guang YangRu-yi ZhengZai-shun Jin Review – Cancer Research Open access 15 October 2019 Pages: 2891 - 2899
Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion Adhiraj RoyGopeshwar Narayan Review – Cancer Research 25 October 2019 Pages: 2901 - 2910
Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer Ying WangYanxia LiuTongmei Zhang Original Article – Cancer Research Open access 23 October 2019 Pages: 2911 - 2920
Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma Xiaolin PengYao LiuDexin Kong Original Article – Cancer Research 16 October 2019 Pages: 2921 - 2936
Are shape morphologies associated with survival? A potential shape-based biomarker predicting survival in lung cancer Maliazurina SaadIk Hyun LeeTae-Sun Choi Original Article – Cancer Research 16 October 2019 Pages: 2937 - 2950
Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo Qianqian JiangYue YuanWen Zhu Original Article – Cancer Research 25 October 2019 Pages: 2951 - 2967
Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome Mithalesh Kumar SinghLata SinghSeema Kashyap Original Article – Cancer Research 14 October 2019 Pages: 2969 - 2982
Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015–2018 Lidija StevanovicMatthias ChoschzickZsuzsanna Varga Original Article – Cancer Research Open access 18 October 2019 Pages: 2983 - 2994
Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis Xialing HuangLiling LongXiangfei Chai Original Article – Cancer Research Open access 29 October 2019 Pages: 2995 - 3003
Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer Yamei ZhaoXiaoxu GeLifeng Sun Review – Clinical Oncology 24 October 2019 Pages: 3005 - 3019
Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors Ning ZhuShanshan WengYing Yuan Review – Clinical Oncology 15 October 2019 Pages: 3021 - 3036
A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis Josias Bastian GroggKym SchneiderChristian Daniel Fankhauser Review – Clinical Oncology 23 October 2019 Pages: 3037 - 3045
Increased risk for cancer after stroke at a young age: etiological relevance or incidental finding? Christian TanislavCharles Christian AdarkwahKarel Kostev Original Article – Clinical Oncology 10 September 2019 Pages: 3047 - 3054
PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy Zhenlin YangJiachen XuJie He Original Article – Clinical Oncology 14 September 2019 Pages: 3055 - 3065
Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas Frank KroschinskyDenise RölligMathias Hänel Original Article – Clinical Oncology 28 September 2019 Pages: 3067 - 3073
ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression Maria-Alexandra PapadimitriouMargaritis AvgerisAndreas Scorilas Original Article – Clinical Oncology 08 October 2019 Pages: 3075 - 3087
The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine Cai XiuXiao LiChunkang Chang Original Article – Clinical Oncology 26 September 2019 Pages: 3089 - 3097
Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancer Andy WangTakefumi Komiya Original Article – Clinical Oncology 23 September 2019 Pages: 3099 - 3104
Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer H. VihervuoriT. A. AutereP. Kronqvist Original Article – Clinical Oncology Open access 27 September 2019 Pages: 3105 - 3114
The effectiveness of Wilms tumor screening in Beckwith–Wiedemann spectrum Alessandro MussaKelly A. DuffyJennifer M. Kalish Original Article – Clinical Oncology 04 October 2019 Pages: 3115 - 3123
“Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation” Neval E. WarehamQiuju LiJens D. Lundgren Original Article – Clinical Oncology 05 November 2019 Pages: 3125 - 3135
